Document Type

Course Project

Publication Date

Winter 2022


Since 2003 when electronic cigarettes (EC) were first introduced to the United States, vaping has rapidly grown in popularity. Originally advertised as a “healthier” alternative to cigarette smoking, it has since been proven that vaping has its own detrimental pathophysiologic effects on the respiratory, cardiovascular, and other organ systems. Additionally, as vaping ingredients are not fully disclosed, health care providers in general do not have a firm understanding of what substances lead to what outcomes. This is of particular concern to the anesthesia provider as perioperatively patients are subject to a multitude of stressors that can cause hemodynamic instability, an issue that is only further compounded by patient use of unknown inhalants. Although the American Association of Nurse Anesthetists (AANA) has published recommendations for anesthetic management of the patient who vapes, it is difficult to translate the recommendations into practice if patient vaping status is not assessed or understood.